Provided by Tiger Trade Technology Pte. Ltd.

Trump Concept

3,334.86
+9.250.28%
Number of Gainers:20
Number of Losers:10
Number of Flat:1
PE:- -
High:3,352.82
Open:3,324.84
Low:3,324.26
Close:3,325.61
Volume:345.36M
Turnover:37.63B
Market Cap:6.28T
Float Cap:5.50T

Loading ...

Merck, Moderna Say Potential Melanoma Therapy Shows 'Statistically Significant Improvement' in Late-Stage Trial

MT Newswires Live
·
Aug 19

Bond Yields, Persian Gulf Outlooks Cap Wall Street Pre-Bell; Asia, Europe Off

MT Newswires Live
·
Aug 19

Morgan Stanley Boosts Stake in SG Micro with 110,900 Share Purchase at Roughly HK$106.19 Each

Stock News
·
Aug 19

Goldman Sachs Boosts Stake in Asymchem with Recent Share Purchase

Stock News
·
Aug 19

JPMorgan Expands Stake in DAJIN with Latest Share Purchase

Stock News
·
Aug 19

Moderna Stock Surges 70%, Merck Rises 6%. at Last, a Successful Cancer Vaccine.

Dow Jones
·
Aug 19

META, MSFT and AMZN Face Rising Costs and Delays as AI Data Center Backlash Grows

TIPRANKS
·
Aug 19

Moderna and Merck Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Unified Communications Platform Helps Businesses Simplify Communications Across Sparklight Service Areas

GlobeNewswire
·
Aug 19

Goldman Sachs Remains a Hold on Natura Cosmeticos SA (NATU3)

TIPRANKS
·
Aug 19

Magazine Luiza S.A. (MGLU3) Receives a Hold from Goldman Sachs

TIPRANKS
·
Aug 19

Skoda CEO Says VW Aims to Finalise India Partner This Year to Share Risk, Drive Growth

Reuters
·
Aug 19

Merck Shares Rise 1.9% Premarket

THOMSON REUTERS
·
Aug 19

AI and Robotics are a Battleground for U.S. and China. This is the Best Bet.

Dow Jones
·
Aug 19

Merck, Moderna Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Merck: Safety Profiles of Intismeran and Keytruda in Trial were Consistent with Prior Reported Studies for the Combination

THOMSON REUTERS
·
Aug 19

Merck: Phase 3 Interpath-001 Trial of Intismeran Autogene Plus Keytruda Met Primary Endpoint of Recurrence Free Survival

THOMSON REUTERS
·
Aug 19

Merck: Co, Moderna Announce Positive Results from Phase 3 Interpath-001 Trial for Patients with Completely Resected Stage Iib-Iv Melanoma

THOMSON REUTERS
·
Aug 19

Musk Robot Rival Soars 460% in China Stock Market Debut

Dow Jones
·
Aug 19

Merck: Co, Moderna Will Engage with Regulators on Filing Submissions for Intismeran Autogene in Combination with Keytruda

THOMSON REUTERS
·
Aug 19